Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptib
暂无分享,去创建一个
N. Kobayashi | M. Fujita | M. Kaku | Tetsuya Matsumoto | Tadahiro Nakamura | K. Yanagihara | M. Suga | Y. Imai | Y. Morinaga | M. Toyokawa | M. Okazaki | N. Miyashita | H. Hanaki | K. Sunakawa | T. Saraya | T. Miyara | S. Iwata | J. Kadota | Y. Niki | H. Tsukada | Y. Ohsaki | Yoshimi Sato | N. Miyazawa | M. Miki | K. Hiramatsu | Koichiro Yoshida | J. Takasaki | Y. Fujikura | A. Kawana | H. Mikamo | K. Mezaki | T. Oguri | M. Yagisawa | J. Sato | K. Ogasawara | A. Watanabe | S. Kawakami | Y. Fujikawa | Y. Aoki | K. Mikasa | H. Tokuyasu | Masaki Yamamoto | M. Kudo | D. Kurai | H. Goto | Y. Koguchi | S. Asari | T. Kumagai | Y. Kawasaki | Tomotaro Wakamura | M. Fukuoka | Toshinobu Yamamoto | H. Nishiya | K. Kasahara | N. Aoki | Masaki Yoshida | Y. Aoki | M. Kuwabara | H. Toda | I. Nishi | N. Kusano | H. Takeda | H. Muranaka | Eri Toyoshima | Kaori Sato | Tomohisa Watari | R. Sano | K. Saionji | K. Takeuchi | S. Nakanowatari | M. Utagawa | H. Konosaki | Y. Honma | K. Masui | K. Negayama | J. Honda | Z. Nagasawa | Yu Yamamoto | M. Shoji | Masahiko Nakamura | Takashi Yoshida | S. Kawasaki | E. Mihara | H. Sawamura | H. Takahashi | Noriko Mitsuno | Yaeko Watanabe | Hiroki Magarifuchi | K. Sugimoto | K. Takeda | Mayumi Shiokoshi | Ayami Tsukada | Nobuyoshi Ban | T. Watari
[1] S. Ichiyama,et al. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012]. , 2014, The Japanese journal of antibiotics.
[2] H. Hanaki,et al. Nationwide survey of the development of drug resistance in the pediatric field in 2007 and 2010: drug sensitivity of Haemophilus influenzae in Japan (second report) , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[3] T. Ezaki,et al. Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens’ antibacterial susceptibility , 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[4] Y. Chong,et al. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan , 2010, European Journal of Clinical Microbiology & Infectious Diseases.
[5] K. Stellrecht,et al. Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin , 2008, Antimicrobial Agents and Chemotherapy.
[6] E. Shimizu,et al. The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility , 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[7] D. Livermore,et al. Evaluation of the chromogenic Cica-beta-Test for detecting extended-spectrum, AmpC and metallo-beta-lactamases. , 2007, The Journal of antimicrobial chemotherapy.
[8] Clinical,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard , 2006 .
[9] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[10] Y. Arakawa,et al. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. , 2000, FEMS microbiology letters.